Interferons and other antiviral drugs in the treatment of hepatitis B and C virus infectionsJIRILLO, Emilio.Current pharmaceutical design. 2002, Vol 8, Num 11, issn 1381-6128, 69 p.Serial Issue

Toll-like receptors and innate immunity: Potential drug targets for treatment of infectious, inflammatory, and autoimmune diseasesJIRILLO, Emilio.Current pharmaceutical design. 2006, Vol 12, Num 32, issn 1381-6128, 191 p.Serial Issue

Immune-Mediated Mechanisms in Atherosclerosis: Prevention and Treatment of Clinical ManifestationsJIRILLO, Emilio.Current pharmaceutical design. 2007, Vol 13, Num 36, issn 1381-6128, 88 p.Serial Issue

In vitro infection of human monocyte-derived dendritic cells with Candida albicans : Receptorial involvement and therapeutic implicationsPEPE, Maria; JIRILLO, Emilio; COVELLI, Vito et al.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4263-4269, issn 1381-6128, 7 p.Article

Early Pathogenesis of Atherosclerosis : The Childhood ObesityAMATI, Luigi; CHILOIRO, Marisa; JIRILLO, Emilio et al.Current pharmaceutical design. 2007, Vol 13, Num 36, pp 3696-3700, issn 1381-6128, 5 p.Article

The Interplay between the Gut Immune System and Microbiota in Health and Disease: Nutraceutical Intervention for Restoring Intestinal HomeostasisMAGRONE, Thea; JIRILLO, Emilio.Current pharmaceutical design (Print). 2013, Vol 19, Num 7, pp 1329-1342, issn 1381-6128, 14 p.Article

Alcohol Influence of polyphenols on allergic immune reactions: mechanisms of actionMAGRONE, Thea; JIRILLO, Emilio.Proceedings of the Nutrition Society. 2012, Vol 71, Num 2, pp 316-321, issn 0029-6651, 6 p.Conference Paper

Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic InterventionsMAGRONE, Thea; JIRILLO, Emilio.Current pharmaceutical design (Print). 2012, Vol 18, Num 12, pp 1609-1619, issn 1381-6128, 11 p.Article

Session 1: Antioxidants and the immune system Polyphenols from red wine are potent modulators of innate and adaptive immune responsivenessMAGRONE, Thea; JIRILLO, Emilio.Proceedings of the Nutrition Society. 2010, Vol 69, Num 3, pp 279-285, issn 0029-6651, 7 p.Conference Paper

Molecular basis for invertebrate innate immune recognition of (1→3)-β-D-glucan as A pathogen-associated molecular patternMUTA, T.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4155-4161, issn 1381-6128, 7 p.Article

TLR2 and TLR4 expression during bacterial infectionsLORENZ, E.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4185-4193, issn 1381-6128, 9 p.Article

Porphyromonas gingivalis Mediated Periodontal Disease and Atherosclerosis : Disparate Diseases with Commonalities in Pathogenesis Through TLRsGIBSON, Frank C; GENCO, Caroline A.Current pharmaceutical design. 2007, Vol 13, Num 36, pp 3665-3675, issn 1381-6128, 11 p.Article

Advanced Glycation : A Novel Outlook on AtherosclerosisPRICE, C. L; KNIGHT, S. C.Current pharmaceutical design. 2007, Vol 13, Num 36, pp 3681-3687, issn 1381-6128, 7 p.Article

Innate immunity in the mucosal immune systemNOCHI, Tomonori; KIYONO, Hiroshi.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4203-4213, issn 1381-6128, 11 p.Article

Treatment of chronic hepatitis BLAGGET, M; RIZZETTO, M.Current pharmaceutical design. 2002, Vol 8, Num 11, pp 953-958, issn 1381-6128Article

New therapies for the Treatment of chronic hepatitis CIDEO, G; BELLOBUONO, A.Current pharmaceutical design. 2002, Vol 8, Num 11, pp 959-966, issn 1381-6128Article

Low Grade Inflammation as a Common Pathogenetic Denominator in Ae-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Succesful Ageing Achievement. Part IICARUSO, Calogero; MAGRONE, Thea; JIRILLO, Emilio et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 7, issn 1381-6128, 153 p.Serial Issue

Leptin and Adipocytokines : Bridging the Gap Between Immunity and AtherosclerosisMATARESE, Giuseppe; MANTZOROS, Christos; LA CAVA, Antonio et al.Current pharmaceutical design. 2007, Vol 13, Num 36, pp 3676-3680, issn 1381-6128, 5 p.Article

Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. Part ICARUSO, Calogero; MAGRONE, Thea; JIRILLO, Emilio et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 6, issn 1381-6128, 172 p.Serial Issue

Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signalingTAKADA, H; UEHARA, A.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4163-4172, issn 1381-6128, 10 p.Article

Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor αKUMAZAWA, Yoshio; KAWAGUCHI, Kiichiro; TAKIMOTO, Hiroaki et al.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4271-4279, issn 1381-6128, 9 p.Article

Non Enzymatic Glycated Proteins in the Blood and Cardiovascular DiseaseMISCIAGNA, G; DE MICHELE, G; TREVISAN, M et al.Current pharmaceutical design. 2007, Vol 13, Num 36, pp 3688-3695, issn 1381-6128, 8 p.Article

Toll-like receptor-positive cells and recognition of pathogens : How human myeloid dendritic cells respond to in vitro infection with Leishmania infantumPEPE, Maria; ALTAMURA, Maria; SPINELLI, Rosa et al.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4255-4262, issn 1381-6128, 8 p.Article

Toll-like receptor signaling mechanisms involved in dendritic cell activation : Potential therapeutic control of T cell polarizationAMATI, Luigi; PEPE, Maria; PASSERI, Maria Elena et al.Current pharmaceutical design. 2006, Vol 12, Num 32, pp 4247-4254, issn 1381-6128, 8 p.Article

Polyploidy: The Link Between Senescence and CancerMOSIENIAK, G; SIKORA, E.Current pharmaceutical design (Print). 2010, Vol 16, Num 6, pp 734-740, issn 1381-6128, 7 p.Article